1 Namiki M, "Working Committee on Clinical Practice Guidelines for Late-onset Hypogonadism; Japanese Urological Association/Japanese Society for Study of Aging Male. Clinical practice manual for late-onset hypogonadism syndrome" 15 : 377-388, 2008
2 Seidell JC, "Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels" 39 : 897-901, 1990
3 de Tejada IS, "Therapeutic strategies for optimizing PDE-5 inhibitor therapy in patients with erectile dysfunction considered difficult or challenging to treat" 16 (16): S40-S42, 2004
4 Travison TG, "The relationship between libido and testosterone levels in aging men" 91 : 2509-2513, 2006
5 Bojesen A, "The metabolic syndrome is frequent in Klinefelter's syndrome and is associated with abdominal obesity and hypogonadism" 29 : 1591-1598, 2006
6 Jones TH, "The effects of testosterone on risk factors for, and the mediators of, the atherosclerotic process" 207 : 318-327, 2009
7 Seo SI, "The effects of androgen on penile reflex, erectile response to electrical stimulation and penile NOS activity in the rat" 1 : 169-174, 1999
8 Traish AM, "The dark side of testosterone deficiency: III. Cardiovascular disease" 30 : 477-494, 2009
9 Ahn HS, "The clinical relevance of sex hormone levels and sexual activity in the ageing male" 89 : 526-530, 2002
10 Gades NM, "The associations between serum sex hormones, erectile function, and sex drive: the Olmsted County Study of Urinary Symptoms and Health Status among Men" 5 : 2209-2220, 2008
11 Stellato RK, "Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study" 23 : 490-494, 2000
12 Brand JS, "Testosterone, sex hormone-binding globulin and the metabolic syndrome: a systematic review and meta-analysis of observational studies" 40 : 189-207, 2011
13 Vermeulen A, "Testosterone, body composition and aging" 22 (22): 110-116, 1999
14 Morales A, "Testosterone supplementation for hypogonadal impotence: assessment of biochemical measures and therapeutic outcomes" 157 : 849-854, 1997
15 Malkin CJ, "Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life" 90 : 871-876, 2004
16 Buvat J, "Testosterone deficiency in men: systematic review and standard operating procedures for diagnosis and treatment" 10 : 245-284, 2013
17 Laaksonen DE, "Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men" 27 : 1036-1041, 2004
18 Liao CH, "Testosterone and sex hormone-binding globulin have significant association with metabolic syndrome in Taiwanese men" 15 : 1-6, 2012
19 Corona G, "Testosterone and metabolic syndrome: a meta-analysis study" 8 : 272-283, 2011
20 Jones TH, "TIMES2 Investigators. Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study)" 34 : 828-837, 2011
21 Morley JE, "Sexuality and disease" 19 : 563-573, 2003
22 Menke A, "Sex steroid hormone concentrations and risk of death in US men" 171 : 583-592, 2010
23 Ding EL, "Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematicreview and meta-analysis" 295 : 1288-1299, 2006
24 Katabami T, "Serum free testosterone and metabolic syndrome in Japanese men" 57 : 533-539, 2010
25 Lanfranco F, "Serum adiponectin levels in hypogonadal males: influence of testosterone replacement therapy" 60 : 500-507, 2004
26 Phillips GB, "Relationship between serum sex hormones and the glucose-insulin-lipid defect in men with obesity" 42 : 116-120, 1993
27 Foresta C, "Reduced number of circulating endothelial progenitor cells in hypogonadal men" 91 : 4599-4602, 2006
28 Oh JY, "Rancho Bernardo Study. Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study" 25 : 55-60, 2002
29 Corona G, "Psychobiologic correlates of the metabolic syndrome and associated sexual dysfunction" 50 : 595-604, 2006
30 Corona G, "Psycho-biological correlates of hypoactive sexual desire in patients with erectile dysfunction" 16 : 275-281, 2004
31 Mulligan T, "Prevalence of hypogonadism in males aged at least 45 years: the HIM study" 60 : 762-769, 2006
32 Baumgartner RN, "Predictors of skeletal muscle mass in elderly men and women" 107 : 123-136, 1999
33 Abbasi AA, "Predictors of lean body mass and total adipose mass in community-dwelling elderly men and women" 315 : 188-193, 1998
34 Zumoff B, "Plasma free and non-sex-hormone-binding- globulin-bound testosterone are decreased in obese men in proportion to their degree of obesity" 71 : 929-931, 1990
35 Haffner SM, "Obesity, body fat distribution and sex hormones in men" 17 : 643-649, 1993
36 Funahashi T, "Metabolic syndrome: clinical concept and molecular basis" 39 : 482-494, 2007
37 Lin JW, "Metabolic syndrome, testosterone, and cardiovascular mortality in men" 8 : 2350-2360, 2011
38 Yassin AA, "Metabolic syndrome, testosterone deficiency and erectile dysfunction never come alone" 40 : 259-264, 2008
39 Carani C, "Marrama P.Testosterone and erectile function, nocturnal penile tumescence and rigidity, and erectile response to visual erotic stimuli in hypogonadal and eugonadal men" 17 : 647-654, 1992
40 English KM, "Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: a randomized, double-blind, placebo-controlled study" 102 : 1906-1911, 2000
41 Svartberg J, "Low testosterone levels are associated with carotid atherosclerosis in men" 259 : 576-582, 2006
42 Akishita M, "Low testosterone level is an independent determinant of endothelial dysfunction in men" 30 : 1029-1034, 2007
43 Akishita M, "Low testosterone level as a predictor of cardiovascular events in Japanese men with coronary risk factors" 210 : 232-236, 2010
44 Haring R, "Low serum testosterone levels are associated with increased risk of mortality in a population-based cohort of men aged 20-79" 31 : 1494-1501, 2010
45 Shores MM, "Low serum testosterone and mortality in male veterans" 166 : 1660-1665, 2006
46 Tsujimura A, "Low serum free testosterone level is associated with carotid intima-media thickness in middle-aged Japanese men" 59 : 809-815, 2012
47 Haffner SM, "Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men. MRFIT Research Group. Multiple Risk Factor Intervention Trial" 143 : 889-897, 1996
48 Mathur A, "Long-term benefits of testosterone replacement therapy on angina threshold and atheroma in men" 161 : 443-449, 2009
49 Torkler S, "Inverse association between total testosterone concentrations, incident hypertension and blood pressure" 14 : 176-182, 2011
50 Whitsel EA, "Intramuscular testosterone esters and plasma lipids in hypogonadal men: a meta-analysis" 111 : 261-269, 2001
51 Nieschlag E, "International Society of Andrology (ISA); International Society for the Study of the Aging Male (ISSAM); European Association of Urology (EAU). Investigation, treatment and monitoring of late-onset hypogonadism in males. ISA, ISSAM, and EAU recommendations" 48 : 1-4, 2005
52 Smith MR, "Insulin sensitivity during combined androgen blockade for prostate cancer" 91 : 1305-1308, 2006
53 Haffner SM, "Insulin resistance, body fat distribution, and sex hormones in men" 43 : 212-219, 1994
54 Mäkinen J, "Increased carotid atherosclerosis in andropausal middle-aged men" 45 : 1603-1608, 2005
55 Hamilton EJ, "Increase in visceral and subcutaneous abdominal fat in men with prostate cancer treated with androgen deprivation therapy" 74 : 377-383, 2011
56 Yassin AA, "Improvement of sexual function in men with late-onset hypogonadism treated with testosterone only" 4 : 497-501, 2007
57 Keymel S, "Impaired endothelial progenitor cell function predicts age-dependent carotid intimal thickening" 103 : 582-586, 2008
58 Corona G, "Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study" 165 : 687-701, 2011
59 Ogbera OA, "Hypogonadism and subnormal total testosterone levels in men with type 2 diabetes mellitus" 21 : 517-521, 2011
60 Beutel ME, "Hypogonadism Investigator Group. Correlations between hormones, physical, and affective parameters in aging urologic outpatients" 47 : 749-755, 2005
61 Buvat J, "Hypogonadal men nonresponders to the PDE5 inhibitor tadalafil benefit from normalization of testosterone levels with a 1% hydroalcoholic testosterone gel in the treatment of erectile dysfunction (TADTEST study)" 8 : 284-293, 2011
62 Dhindsa S, "Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes" 89 : 5462-5468, 2004
63 De Pergola G, "Free testosterone plasma levels are negatively associated with the intima-media thickness of the common carotid artery in overweight and obese glucose- tolerant young adult men" 27 : 803-807, 2003
64 Heufelder AE, "Fifty-two-week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone" 30 : 726-733, 2009
65 Khaw KT, "Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study" 116 : 2694-2701, 2007
66 Ruige JB, "Endogenous testosterone and cardiovascular disease in healthy men: a meta-analysis" 97 : 870-875, 2011
67 Mäkinen JI, "Endogenous testosterone and brachial artery endothelial function in middle-aged men with symptoms of late-onset hypogonadism" 14 : 237-242, 2011
68 Muller M, "Endogenous sex hormones and progression of carotid atherosclerosis in elderly men" 109 : 2074-2079, 2004
69 Muller M, "Endogenous sex hormones and metabolic syndrome in aging men" 90 : 2618-2623, 2005
70 van den Beld AW, "Endogenous hormones and carotid atherosclerosis in elderly men" 157 : 25-31, 2003
71 Bancroft J, "Endocrinology of sexual function" 7 : 253-281, 1980
72 Morales A, "Endocrine aspects of sexual dysfunction in men" 1 : 69-81, 2004
73 Buvat J, "Endocrine aspects of male sexual dysfunctions" 7 : 1627-1656, 2010
74 Aversa A, "Effects of testosterone undecanoate on cardiovascular risk factors and atherosclerosis in middle- aged men with late-onset hypogonadism and metabolic syndrome: results from a 24-month, randomized, doubleblind, placebo-controlled study" 7 : 3495-3503, 2010
75 Kalinchenko SY, "Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double- blinded placebo-controlled Moscow study" 73 : 602-612, 2010
76 Isidori AM, "Effects of testosterone on sexual function in men: results of a meta-analysis" 63 : 381-394, 2005
77 Webb CM, "Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease" 100 : 1690-1696, 1999
78 Haidar A, "Effects of androgen deprivation on glycaemic control and on cardiovascular biochemical risk factors in men with advanced prostate cancer with diabetes" 10 : 189-196, 2007
79 Pasquali R, "Effect of obesity and body fat distribution on sex hormones and insulin in men" 40 : 101-104, 1991
80 Wu FC, "EMAS Group. Identification of late-onset hypogonadism in middle-aged and elderly men" 363 : 123-135, 2010
81 Tajar A, "EMAS Group. Characteristics of androgen deficiency in late-onset hypogonadism: results from the European Male Aging Study (EMAS)" 97 : 1508-1516, 2012
82 Corona G, "Different testosterone levels are associated with ejaculatory dysfunction" 5 : 1991-1998, 2008
83 Hwang TI, "Combined use of androgen and sildenafil for hypogonadal patients unresponsive to sildenafil alone" 18 : 400-404, 2006
84 Kapoor D, "Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity" 30 : 911-917, 2007
85 Smith MR, "Changes in body composition during androgen deprivation therapy for prostate cancer" 87 : 599-603, 2002
86 Tsujimura A, "Bioavailable testosterone with age and erectile dysfunction" 170 : 2345-2347, 2003
87 Empen K, "Association of testosterone levels with endothelial function in men: results from a population-based study" 32 : 481-486, 2012
88 Zitzmann M, "Association of specific symptoms and metabolic risks with serum testosterone in older men" 91 : 4335-4343, 2006
89 Akishita M, "Association of low testosterone with metabolic syndrome and its components in middle-aged Japanese men" 33 : 587-591, 2010
90 Fukui M, "Association between serum testosterone concentration and carotid atherosclerosis in men with type 2 diabetes" 26 : 1869-1873, 2003
91 Morales A, "Andropause: a misnomer for a true clinical entity" 163 : 705-712, 2000
92 Vermeulen A, "Andropause" 34 : 5-15, 2000
93 Reilly CM, "Androgens modulate the alpha-adrenergic responsiveness of vascular smooth muscle in the corpus cavernosum" 18 : 26-31, 1997
94 Nishizawa H, "Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein" 51 : 2734-2741, 2002
95 Mills TM, "Androgens and penile erection: a review" 17 : 633-638, 1996
96 Morley JE, "Androgens and aging" 38 : 61-71, 2001
97 Mårin P, "Androgen treatment of abdominally obese men" 1 : 245-251, 1993
98 Mills TM, "Androgen maintenance of erectile function in the rat penis" 46 : 342-348, 1992
99 Morley JE, "Androgen deficiency in aging men" 83 : 1279-1289, 1999
100 Goldstein BJ, "Adiponectin: a novel adipokine linking adipocytes and vascular function" 89 : 2563-2568, 2004
101 Ryo M, "Adiponectin as a biomarker of the metabolic syndrome" 68 : 975-981, 2004
102 Tsujimura A, "Adiponectin and testosterone in patients with symptoms of late-onset hypogonadism: is there a link?" 16 : 830-835, 2009